Vaxxinova releases new product

Vaxxinova US is pleased to announce the latest addition to its vaccine portfolio with the first and only fully-licensed inactivated E. coli vaccine in the U.S. poultry market – Vaxxon® SRP® E.coli-SE. This product, using innovative SRP Technology, is a combination E. coli and Salmonella Enteritidis vaccine for long-lived birds. This vaccine was developed to reduce mortality related to E. coli infection and reduction of Salmonella Enteritidis colonization in the reproductive tract, internal organs and intestinal tract. Read more